Related Experiment Video
Updated: Aug 5, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis
María Paula Zafra-Sierra1,2, Carolina Ferreira-Atuesta3, Daniela Sofía Rodríguez1,2
1Department of Neurology, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
European Journal of Neurology
|August 1, 2026
Summary
Younger age, multifocal presentation, and specific MRI/CSF findings increase the risk of multiple sclerosis (MS) after a clinically isolated syndrome (CIS). These factors aid in identifying high-risk individuals for personalized MS treatment strategies.
Area of Science:
- Neurology
- Neuroimmunology
- Clinical Medicine
Background:
- Multiple sclerosis (MS) often begins with a clinically isolated syndrome (CIS).
- Not all individuals experiencing CIS are ultimately diagnosed with MS.
- Identifying predictors of MS conversion from CIS is crucial for early intervention.
Purpose of the Study:
- To systematically review and meta-analyze factors associated with the conversion of CIS to MS.
- To identify specific clinical, imaging, and cerebrospinal fluid (CSF) markers that predict MS diagnosis.
Main Methods:
- Systematic literature review conducted up to December 2025.
- Inclusion of observational studies on adults with CIS who later developed MS.
- Random-effects meta-analysis of pooled odds ratios (ORs), with heterogeneity assessed using I² statistics.
Main Results:
- Younger age (OR=1.6) and multifocal presentation (OR=1.55) were linked to higher MS risk.
- Specific MRI findings, including T2 lesions (OR=7.46), periventricular lesions (OR=4.08), and corpus callosum lesions (OR=14.89), significantly predicted MS.
- Cerebrospinal fluid markers like oligoclonal bands (OR=3.57) and pleocytosis (OR=3.34) were also associated with increased MS likelihood.
Conclusions:
- This meta-analysis highlights key factors predicting MS development post-CIS.
- Findings support the identification of high-risk individuals for tailored treatment approaches.
- Early identification can potentially optimize management and outcomes for patients with CIS.
